Current and historical daily PE Ratio for Enwei Pharmaceutical Co Ltd (
SZSE:301331
) from 2022 to Jun 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Enwei Pharmaceutical stock (SZSE:301331) PE ratio as of Jun 16 2024 is 38.55.
More Details
Enwei Pharmaceutical Co Ltd (SZSE:301331) PE Ratio (TTM) Chart
Enwei Pharmaceutical Co Ltd (SZSE:301331) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 423
- 1
- 2
- 3
- 4
- 5
| Enwei Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-16 | 38.5 | 2024-04-11 | 39.5 |
| 2024-06-14 | 38.5 | 2024-04-10 | 38.6 |
| 2024-06-13 | 37.7 | 2024-04-09 | 39.0 |
| 2024-06-12 | 40.2 | 2024-04-08 | 37.6 |
| 2024-06-11 | 40.2 | 2024-04-05 | 38.1 |
| 2024-06-07 | 42.2 | 2024-04-03 | 38.1 |
| 2024-06-06 | 41.4 | 2024-04-02 | 38.0 |
| 2024-06-05 | 39.7 | 2024-04-01 | 37.9 |
| 2024-06-04 | 40.6 | 2024-03-29 | 37.1 |
| 2024-06-03 | 40.2 | 2024-03-28 | 36.7 |
| 2024-05-31 | 41.4 | 2024-03-27 | 28.6 |
| 2024-05-30 | 40.8 | 2024-03-26 | 28.6 |
| 2024-05-29 | 41.1 | 2024-03-25 | 28.4 |
| 2024-05-28 | 40.8 | 2024-03-22 | 29.1 |
| 2024-05-27 | 42.1 | 2024-03-21 | 30.0 |
| 2024-05-24 | 41.3 | 2024-03-20 | 30.2 |
| 2024-05-23 | 42.5 | 2024-03-19 | 29.9 |
| 2024-05-22 | 43.4 | 2024-03-18 | 30.1 |
| 2024-05-21 | 44.8 | 2024-03-15 | 29.5 |
| 2024-05-20 | 45.2 | 2024-03-14 | 29.4 |
| 2024-05-17 | 44.2 | 2024-03-13 | 29.3 |
| 2024-05-16 | 43.9 | 2024-03-12 | 30.0 |
| 2024-05-15 | 43.3 | 2024-03-11 | 28.4 |
| 2024-05-14 | 43.5 | 2024-03-08 | 28.1 |
| 2024-05-13 | 41.6 | 2024-03-07 | 27.9 |
| 2024-05-10 | 42.1 | 2024-03-06 | 28.4 |
| 2024-05-09 | 42.9 | 2024-03-05 | 28.8 |
| 2024-05-08 | 43.1 | 2024-03-04 | 30.0 |
| 2024-05-07 | 43.2 | 2024-03-01 | 28.3 |
| 2024-05-06 | 43.2 | 2024-02-29 | 28.0 |
| 2024-05-03 | 43.1 | 2024-02-28 | 27.7 |
| 2024-05-02 | 43.1 | 2024-02-27 | 29.1 |
| 2024-04-30 | 43.1 | 2024-02-26 | 28.2 |
| 2024-04-29 | 42.5 | 2024-02-23 | 28.3 |
| 2024-04-26 | 39.7 | 2024-02-22 | 27.5 |
| 2024-04-25 | 39.4 | 2024-02-21 | 26.8 |
| 2024-04-24 | 39.6 | 2024-02-20 | 26.9 |
| 2024-04-23 | 39.9 | 2024-02-19 | 26.2 |
| 2024-04-22 | 39.7 | 2024-02-16 | 25.8 |
| 2024-04-19 | 42.0 | 2024-02-09 | 25.8 |
| 2024-04-18 | 39.7 | 2024-02-08 | 25.8 |
| 2024-04-17 | 40.1 | 2024-02-07 | 24.2 |
| 2024-04-16 | 38.9 | 2024-02-06 | 24.9 |
| 2024-04-15 | 38.3 | 2024-02-05 | 23.9 |
| 2024-04-12 | 38.5 | 2024-02-02 | 25.9 |
Enwei Pharmaceutical Co Ltd (SZSE:301331) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Enwei Pharmaceutical Co Ltd
ISIN : CNE100005LC7
Share Class Description:
SZSE:301331: Class ACompare
Compare
Traded in other countries / regions
301331.China IPO Date
2022-09-21Description
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers